Evaluation of the Overall Survival of Meclinertant Versus Placebo After a First Line Chemotherapy With Cisplatin + Etoposide
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Lung Cancer
Related studies linked through entity extraction aliases.
Phase II Study of ZD6474 in Advanced NSCLC
- Status
- TERMINATED
- Phase
- PHASE2
Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE3
Interaction of Docetaxel and Lonafarnib in Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
S0429: Docetaxel, Cetuximab, and Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Topotecan and Vinorelbine in Treating Patients With Recurrent Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Vinflunine in the Treatment of Patients With Relapsed Extensive Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Ph II Gemcitabine, Erlotinib, and Gemcitabine With Erlotinib/Elderly Patients W/ IIIB/IV NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
VNP40101M in Treating Patients With Relapsed or Refractory Locally Advanced or Metastatic Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel and Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer That Has Been Completely Removed By Surgery
- Status
- COMPLETED
- Phase
- PHASE2
Carboplatin, Gemcitabine, and Thalidomide in Patients Undergoing Surgery for Stage II or III Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Whole-Brain Radiation Therapy and Pemetrexed in Treating Patients With Brain Metastases From Non-Small Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Ph II Adjuvant Carboplatin/Docetaxel in Curatively Resected Stage I-IIIA NSCLC
- Status
- COMPLETED
- Phase
- PHASE2
Detection of Genetic Markers of Lung Cancer
- Status
- RECRUITING
- Phase
- N/A
Combination Chemotherapy, Bev, RT, and Erlotinib in Treating Patients With Stage III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Gemcitabine and Docetaxel in Treating Patients With Recurrent Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Volociximab and Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Erlotinib, Paclitaxel, and Carboplatin Combined With Radiation Therapy for Stage III Non-Small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer
- Status
- COMPLETED
- Phase
- PHASE4